http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0730593-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1c89ce4d9ac03f9acd8ddede1162f94d |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-06 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-06 |
filingDate | 1994-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_16f482ff7a65c6dd909b6458ff4e4a0f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c72063c0b7ccf109cf1d35342af33d2e |
publicationDate | 1996-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | EP-0730593-A1 |
titleOfInvention | Morpholine derivatives as dopamine receptor subtype ligands |
abstract | A class of substituted morpholine derivatives of formula (I), wherein Y represents an optionally substituted bicyclid heteroaromatic ring system containing one or two nitrogen atoms, the ring system comprising a six-membered aromatic or heteroaromatic ring fused to a five- or six-membered heteroaromatic ring; and Z represents an optionally substituted arylalkyl, aryloxymethyl or arylalkoxymethyl group, are ligands for dopamine receptor subtypes within the body and are therefore useful in the treatment and/or prevention of disorders of the dopamine system, in particular schizophrenia. |
priorityDate | 1993-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 317.